Benefit of extending the dosing interval of paliperidone palmitate on schizophrenics with mild cognitive dysfunction

Authors :: Hideo Matsumoto
Ayako Mikami
Hiroyuki Hibino
Katsunaka Mikami
Hidenobu Suzuki
Yuichi Inoue
Source :: Asian Journal of Psychiatry. 28:98-99
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Paliperidone Palmitate
medicine.medical_specialty
business.industry
Cognition
General Medicine
030227 psychiatry
03 medical and health sciences
Psychiatry and Mental health
0302 clinical medicine
Text mining
Internal medicine
medicine
Dosing interval
business
030217 neurology & neurosurgery
General Psychology

Full Text Access

Tools